Category Archives: Pr Newswire

TIANJIN, China, June 22, 2024 /PRNewswire/ — On June 20th, Tianjin hosted the opening of the 2024 World Intelligence Expo (WIE). Under the theme “Intelligence: Expansive Development Space, Sustainable Growth Driver,” the event was co-organized by the people’s governments of the Tianjin and Chongqing municipalities. Wan Gang made a keynote speech. Chinese President Xi Jinping sent […]

HEFEI, China, June 21, 2024 /PRNewswire/ — VIAIM, an AI technology hardware company deeply rooted in the smart office sector, has announced the upgrade of its brand-new official website, showcasing its innovative wireless earbuds. The upgraded website put spotlight on its flagship products, the AI Recoding True Wireless Earbuds VIAIM Nano+ and the Open-ear AI Recording True Wireless […]

Lexicon Seeks Approval for Sotagliflozin as an Adjunct to Insulin Therapy for Glycemic Control in People with Type 1 Diabetes and Chronic Kidney Disease Company Anticipates Six Month Review and Potential Launch in Early 2025 THE WOODLANDS, Texas, June 21, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that, following multiple interactions […]

Webinar will include discussion of APR-1051 in context of emerging WEE1 inhibitor landscape DOYLESTOWN, Pa., June 21, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that it will host a virtual KOL event to discuss APR-1051, a […]

Patient Enrollment in Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 On-Track for Potential NDA Submission in 1H Calendar 2025 Projected Cash Runway into Second Calendar Quarter 2026 PRINCETON, N.J., June 21, 2024 (GLOBE NEWSWIRE) —  Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation […]

CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on June 27, 2024, at 4:15 p.m. ET. The exclusive event, hosted by […]

CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome, a rare pediatric neurodevelopmental disease CNM-Au8 also demonstrated rescue of mitochondrial deficits in induced astrocytes derived from Rett patients Invited oral presentation and poster presented on June 19, 2024, at the International Rett Syndrome Foundation 2024 Annual Meeting in Westminster, Colorado SALT LAKE […]

BEIJING, June 21, 2024 /PRNewswire/ —  A report from China Daily: China’s status as a leading industrial powerhouse in the world will become even more pronounced in the era of AI, as artificial intelligence technology continues to advance in China and the digitalization of the manufacturing industry progresses further, said business leaders and experts on […]

BEIJING, June 21, 2024 /PRNewswire/ — 36Kr Holdings Inc. (“36Kr” or the “Company”) (NASDAQ: KRKR), a prominent brand and pioneering platform dedicated to serving New Economy participants in China, today announced that it has entered into a strategic partnership with SenseTime, a leading global artificial intelligence (AI) software company, to embed Artificial General Intelligence (“AGI”) technology […]

CASTRES, France, June 21, 2024 /PRNewswire/ — Pierre Fabre Laboratories has been awarded the “Prix Galien International” Prize in the “Best Product for a Rare/Orphan Disease” category for EBVALLO® (tabelecleucel), indicated as monotherapy for the treatment of patients with post-transplant lymphoproliferative disorder positive for Epstein-Barr virus (EBV+ PTLD) who have received at least one prior treatment.  […]